|
End-of-day quote
Buenos Aires S.E.
2026-09-14
|
5-day change | 1st Jan Change | ||
| 65,375.00 ARS | +2.07% |
|
+0.69% | -7.34% |
| 03:03pm | Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says | MT |
| 01:28pm | AstraZeneca Chair Demare acquires 2,500 shares | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,015B | |||||
| 642B | - | ||||
| 463B | |||||
| 353B | |||||
| 265B |
Select your edition
All financial news and data tailored to specific country editions
